Wedbush Securities Inc. Purchases 3,425 Shares of Lam Research Corporation $LRCX

Wedbush Securities Inc. boosted its position in Lam Research Corporation (NASDAQ:LRCXFree Report) by 19.5% during the second quarter, according to its most recent 13F filing with the SEC. The firm owned 20,968 shares of the semiconductor company’s stock after acquiring an additional 3,425 shares during the period. Wedbush Securities Inc.’s holdings in Lam Research were worth $2,041,000 as of its most recent SEC filing.

Other institutional investors have also added to or reduced their stakes in the company. Empowered Funds LLC lifted its stake in Lam Research by 10.5% in the first quarter. Empowered Funds LLC now owns 187,472 shares of the semiconductor company’s stock worth $13,629,000 after acquiring an additional 17,833 shares during the period. Genus Capital Management Inc. bought a new position in Lam Research in the 2nd quarter worth $14,476,000. Cookson Peirce & Co. Inc. bought a new position in Lam Research in the 1st quarter worth $607,000. Glass Wealth Management Co LLC lifted its position in shares of Lam Research by 8.5% in the 2nd quarter. Glass Wealth Management Co LLC now owns 28,870 shares of the semiconductor company’s stock worth $2,810,000 after purchasing an additional 2,270 shares during the period. Finally, First Interstate Bank bought a new stake in shares of Lam Research during the 2nd quarter valued at about $230,000. 84.61% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of equities analysts recently issued reports on LRCX shares. BNP Paribas Exane increased their price target on shares of Lam Research from $80.00 to $140.00 and gave the stock a “neutral” rating in a research note on Thursday, October 23rd. Stifel Nicolaus set a $160.00 target price on Lam Research and gave the stock a “buy” rating in a report on Thursday, October 23rd. Rothschild & Co Redburn increased their target price on Lam Research from $140.00 to $150.00 and gave the stock a “buy” rating in a research report on Tuesday, October 14th. Oppenheimer set a $200.00 target price on Lam Research and gave the company an “outperform” rating in a research note on Thursday, October 23rd. Finally, Evercore ISI upped their price target on Lam Research from $115.00 to $170.00 and gave the stock an “outperform” rating in a research note on Thursday, October 23rd. One research analyst has rated the stock with a Strong Buy rating, twenty-six have assigned a Buy rating and nine have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, Lam Research presently has an average rating of “Moderate Buy” and an average price target of $148.54.

Read Our Latest Stock Analysis on LRCX

Insider Activity at Lam Research

In other Lam Research news, Director Bethany Mayer sold 1,298 shares of the firm’s stock in a transaction dated Monday, November 3rd. The shares were sold at an average price of $159.99, for a total transaction of $207,667.02. Following the completion of the sale, the director directly owned 1,652 shares in the company, valued at approximately $264,303.48. This trade represents a 44.00% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Vahid Vahedi sold 52,190 shares of Lam Research stock in a transaction dated Monday, October 13th. The stock was sold at an average price of $138.90, for a total transaction of $7,249,191.00. Following the completion of the transaction, the senior vice president directly owned 251,047 shares of the company’s stock, valued at $34,870,428.30. This trade represents a 17.21% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders have sold 62,498 shares of company stock valued at $8,875,663. 0.31% of the stock is owned by insiders.

Lam Research Stock Performance

Shares of LRCX opened at $159.35 on Friday. The company has a quick ratio of 1.60, a current ratio of 2.21 and a debt-to-equity ratio of 0.37. The stock has a market cap of $200.15 billion, a P/E ratio of 35.10, a P/E/G ratio of 1.68 and a beta of 1.87. The business’s 50 day moving average price is $134.94 and its 200-day moving average price is $106.61. Lam Research Corporation has a 52 week low of $56.32 and a 52 week high of $166.92.

Lam Research (NASDAQ:LRCXGet Free Report) last posted its quarterly earnings data on Wednesday, October 22nd. The semiconductor company reported $1.26 earnings per share for the quarter, beating analysts’ consensus estimates of $1.22 by $0.04. Lam Research had a return on equity of 60.60% and a net margin of 29.66%.The company had revenue of $5.32 billion during the quarter, compared to analyst estimates of $5.23 billion. During the same quarter last year, the company earned $0.86 EPS. The firm’s revenue for the quarter was up 27.7% on a year-over-year basis. Lam Research has set its Q2 2026 guidance at 1.050-1.250 EPS. Equities research analysts anticipate that Lam Research Corporation will post 3.71 earnings per share for the current fiscal year.

Lam Research Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 7th. Investors of record on Wednesday, December 3rd will be paid a $0.26 dividend. The ex-dividend date is Wednesday, December 3rd. This represents a $1.04 dividend on an annualized basis and a yield of 0.7%. Lam Research’s payout ratio is presently 22.91%.

Lam Research Profile

(Free Report)

Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits. The company offers ALTUS systems to deposit conformal films for tungsten metallization applications; SABRE electrochemical deposition products for copper interconnect transition that offers copper damascene manufacturing; SOLA ultraviolet thermal processing products for film treatments; and VECTOR plasma-enhanced CVD ALD products.

Read More

Want to see what other hedge funds are holding LRCX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Lam Research Corporation (NASDAQ:LRCXFree Report).

Institutional Ownership by Quarter for Lam Research (NASDAQ:LRCX)

Receive News & Ratings for Lam Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lam Research and related companies with MarketBeat.com's FREE daily email newsletter.